Meridian Bioscience DSO Ratio 2011-2026 | VIVO

Annual DSO Ratio Meridian Bioscience

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
55.2	52.9	53.3	64.7	55.3	52.9	50.4	49.2	44.9	50.6	50.9	56.8

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
64.7	44.9	53.1

Quarterly DSO Ratio Meridian Bioscience

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
71.2	-	-	42.5	50.5	-	68.8	50.6	39	54.8	41.4	36.2	69.3	64.9	67.1	64.8	56.8	55.6	57	52.1	53.4	53.4	53	45	50.1	52.6	48.8	53.3	52.1	50.9	49.7	48.2	44.5	45.4	44.9	43.5	49.6	48.8	50.7	50.9	48.3	50.8	52.6	48.5	55.6	54.8	56.6	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
71.2	36.2	52.2

DSO Ratio of other stocks in the Diagnostics research industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	145	-	-6.23 %	$ 30.6 M	Germany
Accelerate Diagnostics AXDX	291	-	-61.36 %	$ 2.46 M	USA
Agilent Technologies A	63.8	$ 118.25	-1.25 %	$ 35.9 B	USA
Burning Rock Biotech Limited BNR	31.7	-	-	$ 236 M	China
Aspira Women's Health AWH	1.17 K	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	112	-	-13.05 %	$ 7.29 M	USA
Chembio Diagnostics CEMI	66.3	-	0.22 %	$ 16.8 M	USA
DermTech DMTK	80.6	-	-11.32 %	$ 2.94 M	USA
Medpace Holdings MEDP	50.4	$ 515.65	-0.56 %	$ 14.9 B	USA
CareDx, Inc CDNA	51.5	$ 22.42	27.6 %	$ 1.19 B	USA
Oxford Immunotec Global PLC OXFD	90.8	-	-	$ 562 M	Britain
NeoGenomics NEO	77.7	$ 8.16	-5.99 %	$ 1.05 B	USA
Neogen Corporation NEOG	66.6	$ 9.24	-1.91 %	$ 2 B	USA
Akumin AKU	57.4	-	-17.87 %	$ 25.9 M	Canada
Exact Sciences Corporation EXAS	30.8	-	-	$ 19.8 B	USA
Enzo Biochem ENZ	50.3	-	-8.98 %	$ 14.8 K	USA
Co-Diagnostics CODX	94.7	$ 1.46	2.82 %	$ 1.94 M	USA
Castle Biosciences CSTL	49.2	-	-	$ 684 M	USA
Senseonics Holdings SENS	10.3	$ 6.77	-1.88 %	$ 282 M	USA
Soleno Therapeutics SLNO	27	$ 52.57	-	$ 2.67 B	USA
Global Cord Blood Corporation CO	112	-	-	$ 399 M	China
Fluidigm Corporation FLDM	67.2	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	11.7 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	122	-	0.12 %	$ 80.1 M	China
Neuronetics STIM	48.7	$ 1.4	0.72 %	$ 92.3 M	USA
Charles River Laboratories International CRL	65	$ 176.94	-2.0 %	$ 8.77 B	USA
PRA Health Sciences, Inc. PRAH	98.1	-	-	$ 10.7 B	USA
Thermo Fisher Scientific TMO	70	$ 516.0	-2.95 %	$ 195 B	USA
Danaher Corporation DHR	55.3	$ 193.78	-2.2 %	$ 138 B	USA
Interpace Biosciences IDXG	66.9	$ 2.2	-	$ 9.73 M	USA
Trinity Biotech plc TRIB	87.2	$ 0.7	-0.54 %	$ 61.9 M	Irlanda
Heska Corporation HSKA	40.8	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	101	-	-20.0 %	$ 1.06 M	USA
Twist Bioscience Corporation TWST	44.5	$ 56.23	-2.41 %	$ 3.36 B	USA
Illumina ILMN	61.3	$ 132.72	0.35 %	$ 21.1 B	USA
Fulgent Genetics FLGT	77.4	$ 16.13	-0.25 %	$ 488 M	USA
Guardant Health GH	46.1	$ 85.7	0.99 %	$ 10.7 B	USA
QIAGEN N.V. QGEN	30.8	-	-	$ 10.6 B	Niderland
Anixa Biosciences ANIX	275	$ 2.83	-3.41 %	$ 91.8 K	USA
Biomerica BMRA	57.7	$ 2.2	4.27 %	$ 5.05 M	USA
Waters Corporation WAT	306	$ 319.04	-2.19 %	$ 19 B	USA
ICON Public Limited Company ICLR	68.5	$ 115.58	-0.79 %	$ 9.53 B	Irlanda
Laboratory Corporation of America Holdings LH	52.9	$ 266.36	-0.14 %	$ 22.2 B	USA
Motus GI Holdings MOTS	77.2	-	-34.28 %	$ 263 K	Israel
Myriad Genetics MYGN	52.3	$ 5.0	-3.66 %	$ 463 M	USA
Lantheus Holdings LNTH	80.5	$ 83.92	-0.02 %	$ 5.66 B	USA
Quest Diagnostics Incorporated DGX	44.9	$ 191.46	0.02 %	$ 21.3 B	USA